August 5, 2011 -- Hebei Changshan Biochemical Pharmaceutical hopes to raise 756 million RMB ($117.4 million) on the ChiNext Exchange. The underwriters will seek to place 27 million shares at a price of 28 RMB each. Changshan Biochemical is a heparin maker and derives 87% of its revenues from heparin APIs. More details....
Stock Symbol: (SHE: 300255)
